1887

Abstract

Eradication treatment for is known to cause mild but relatively frequent adverse effects. Some adverse effects such as diarrhoea and soft stools are related to disruption of the composition of the intestinal microflora. This study investigated the microfloral changes resulting from administration of an eradication regimen using proton pump inhibitor (PPI), amoxycillin and clarithromycin. Twenty-eight laboratory-bred Japanese macaques either were administered eradication treatment by this regimen for 7 days or received no medication. Faecal samples were collected for analysis on days 0, 8 and 15, and both aerobic and anaerobic cultures were performed. Among aerobic bacteria, had significantly decreased by day 8, while and had significantly increased. However, the total number of aerobic bacteria was not significantly decreased from pretreatment levels 1 day after completion of treatment. The number of anaerobic bacteria did not change significantly by day 8. However, the number of and the detection rate of , and significantly decreased by day 8, although the number of , and had almost recovered up to the pretreatment levels 1 week after completion of treatment (day 15). These results suggest that the alterations in the composition of the intestinal microflora caused by the antimicrobial regimen that excludes metronidazole are different from those caused by the regimen including this drug. However, the alterations in bacterial microflora had almost reversed 7 days after completion of treatment in these macaques, which supports clinical findings that diarrhoea or soft stools in humans resolve relatively quickly after a similar treatment.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45814-0
2005-03-01
2019-11-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/3/JM540315.html?itemId=/content/journal/jmm/10.1099/jmm.0.45814-0&mimeType=html&fmt=ahah

References

  1. Adamsson, I., Nord, C. E., Lundquist, P., Sjöstedt, S. & Edlund, C. ( 1999;). Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 44, 629–640.[CrossRef]
    [Google Scholar]
  2. Armuzzi, A., Cremonini, F., Ojetti, V. & 9 other authors ( 2001;). Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 63, 1–7.
    [Google Scholar]
  3. Asaka, M., Satoh, K., Sugano, K. & 7 other authors ( 2001;). Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 6, 177–186.[CrossRef]
    [Google Scholar]
  4. Bartlett, J. G. ( 2002;). Clinical practice.Antibiotic-associated diarrhea. N Engl J Med 346, 334–339.[CrossRef]
    [Google Scholar]
  5. Benno, Y., Itoh, K., Miyao, Y. & Mitsuoka, T. ( 1987;). Comparison of fecal microflora between wild Japanese monkeys in a snowy area and laboratory-reared Japanese monkeys. Jpn J Vet Sci 49, 1059–1064 (in Japanese).[CrossRef]
    [Google Scholar]
  6. Brismar, B., Edlund, C. & Nord, C. E. ( 1991;). Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora. Scand J Infect Dis 23, 635–642.[CrossRef]
    [Google Scholar]
  7. Brismar, B., Edlund, C. & Nord, C. E. ( 1993;). Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 12, 714–719.[CrossRef]
    [Google Scholar]
  8. Bühling, A., Radun, D., Müller, W. A. & Malfertheiner, P. ( 2001;). Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther 15, 1445–1452.[CrossRef]
    [Google Scholar]
  9. Cremonini, F., Di Caro, S., Covino, M. & 7 other authors ( 2002;). Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97, 2744–2749.[CrossRef]
    [Google Scholar]
  10. Edlund, C., Stark, C. & Nord, C. E. ( 1994;). The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrob Chemother 34, 127–138.[CrossRef]
    [Google Scholar]
  11. Edlund, C., Alván, G., Barkholt, L., Vacheron, F. & Nord, C. E. ( 2000a;). Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. J Antimicrob Chemother 46, 741–749.[CrossRef]
    [Google Scholar]
  12. Edlund, C., Beyer, G., Hiemer-Bau, M., Ziege, S., Lode, H. & Nord, C. E. ( 2000b;). Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis 32, 81–85.[CrossRef]
    [Google Scholar]
  13. Floor, M., van Akkeren, F., Rozenberg-Arska, M., Visser, M., Kolsters, A., Beumer, H. & Verhoef, J. ( 1994;). Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis. Scand J Infect Dis 26, 191–197.[CrossRef]
    [Google Scholar]
  14. Fukuda, Y., Tamura, K., Yamamoto, I., Kawaura, A., Tonokatsu, W., Tsuyuguchi, T., Ohno, T., Satomi, M. & Shimoyama, T. ( 1992;). Inoculation of rhesus monkeys with human Helicobacter pylori: a long-term investigation on gastric mucosa by endoscopy. Dig Endosc 4, 19–30.[CrossRef]
    [Google Scholar]
  15. Fukuda, Y., Shintani, S., Okui, M., Yamamoto, I., Tamura, K. & Shimoyama, T. ( 1998;). Intestinal microflora after eradication treatment for Helicobacter pylori infection in Japanese monkeys. Syouka to Kyusyu 21, 65–68 (in Japanese).
    [Google Scholar]
  16. Högenauer, C., Hammer, H. F., Krejs, G. J. & Reisinger, E. C. ( 1998;). Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27, 702–710.[CrossRef]
    [Google Scholar]
  17. Lind, T., Veldhuyzen van Zanten, S., Unge, P. & 8 other authors ( 1996;). Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1, 138–144.[CrossRef]
    [Google Scholar]
  18. Misiewicz, J. J., Harris, A. W., Bardhan, K. D. & 7 other authors ( 1997;). One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 41, 735–739.[CrossRef]
    [Google Scholar]
  19. Mitsuoka, T. ( 1980;). The world of intestinal bacteria. In A Color Atlas of Anaerobic Bacteria. Tokyo: Sohbunsya (in Japanese).
  20. Mitsuoka, T. & Kaneuchi, C. ( 1977;). Ecology of the bifidobacteria. Am J Clin Nutr 30, 1799–1810.
    [Google Scholar]
  21. Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H. ( 1999;). Manual of Clinical Microbiology, 7th edn. Washington, DC; American Society for Microbiology.
  22. Sharma, V. K., Vasudeva, R. & Howden, C. W. ( 1999;). A survey of gastroenterologists’ perceptions and practices related to Helicobacter pylori infection. Am J Gastroenterol 94, 3170–3174.[CrossRef]
    [Google Scholar]
  23. Simon, G. L. & Gorbach, S. L. ( 1984;). Intestinal flora in health and disease. Gastroenterology 86, 174–193.
    [Google Scholar]
  24. Stark, C. A., Adamsson, I., Edlund, C., Sjösted, S., Seensalu, R., Wikström, B. & Nord, C. E. ( 1996;). Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother 38, 927–939.[CrossRef]
    [Google Scholar]
  25. Sullivan, A., Edlund, C. & Nord, C. E. ( 2001;). Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1, 101–114.[CrossRef]
    [Google Scholar]
  26. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. & Schlemper, R. J. ( 2001;). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784–789.[CrossRef]
    [Google Scholar]
  27. Van der Hulst, R. W., Rauws, E. A., Köycü, B., Keller, J. J., Bruno, M. J., Tussen, J. G. & Tytgat, G. N. ( 1997;). Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 113, 1082–1086.[CrossRef]
    [Google Scholar]
  28. Wotherspoon, A. C., Doglioni, C., Diss, T. C., Pan, L., Moschini, A., der Boni, M. & Isaacson, P. G. ( 1993;). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575–577.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45814-0
Loading
/content/journal/jmm/10.1099/jmm.0.45814-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error